PRESS RELEASE published on 03/28/2023 at 12:30, 2 years ago Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/20/2023 at 07:00, 2 years ago Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE published on 03/17/2023 at 07:00, 2 years ago Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/14/2023 at 07:00, 2 years ago Newron announces 2022 financial results and provides outlook for 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 2 years 1 month ago Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
PRESS RELEASE published on 01/03/2023 at 07:00, 2 years 3 months ago Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Published on 04/10/2025 at 02:30, 39 minutes ago Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/09/2025 at 23:30, 3 hours 39 minutes ago AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 4 hours 52 minutes ago Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Published on 04/09/2025 at 22:05, 5 hours 4 minutes ago Amdocs Announces Q3F25 Investor Conference Schedule
Published on 04/09/2025 at 20:20, 6 hours 49 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 6 hours 51 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 8 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:45, 8 hours 24 minutes ago EUROPLASMA: Précisions dans le cadre du projet de reprise de la Fonderie de Bretagne
Published on 04/09/2025 at 18:34, 8 hours 35 minutes ago PolyPeptide announces results of the annual General Meeting 2025
Published on 04/09/2025 at 18:59, 8 hours 9 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 8 hours 9 minutes ago Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 8 hours 12 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 8 hours 12 minutes ago Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 9 hours 24 minutes ago COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.
